A challenge to the seven widely believed concepts of COPD

International Journal of COPD

Volumn 8, Issue , 2013, Pages 21-30

  Al Kassimi, Feisal A ^a   Alhamad, Esam H ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Asthma; Computerized tomography; COPD; Global initiative for chronic obstructive lung disease; Overlap syndrome

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE PLUS FORMOTEROL; CARBON MONOXIDE; CORTICOSTEROID; FLUTICASONE PROPIONATE PLUS SALMETEROL; PREDNISOLONE; SALBUTAMOL;

ASTHMA; BRONCHIECTASIS; BRONCHUS BIOPSY; CD4 CD8 RATIO; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT; COMPUTER ASSISTED TOMOGRAPHY; CYTOLOGY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG RESPONSE; DYSPNEA; EMPHYSEMA; EOSINOPHIL COUNT; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HISTOPATHOLOGY; HUMAN; NEUTROPHIL CHEMOTAXIS; PHENOTYPE; QUALITATIVE ANALYSIS; REVIEW; SENSITIVITY AND SPECIFICITY; SMOKING HABIT;

EID: 84872928658     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S38714     Document Type: Review

References (81)

1. Global Initiative for Chronic Obstructive Pulmonary Disease. Updated 2010. Available from: http://www.goldcopd.org. Accessed September 15, 2012.
2. Tsuda Y, Noguchi T, Mochizuki H, et al. Patients with mild-to-moderate asthma may develop clinically significant chronic obstructive pulmonary disease. Respirology. 2009;14(4):529-536.
3. Bellia V, Battaglia S, Catalano F, et al. Aging and disability affect misdiagnosis of COPD in elderly asthmatics: the SARA study. Chest. 2003;123(4):1066-1072.
4. Ulrik CS, Backer V. Nonreversible airflow obstruction in life-long nonsmokers with moderate to severe asthma. Eur Respir J. 1999; 14(4):892-896.
5. ten Brinke A: Risk factors associated with irreversible airflow limitation in asthma. Curr Opin Allergy Clin Immunol. 2008;8(1):63-69.
6. Dik N, Anthonisen NR, Manfreda J, Roos LL. Physician-diagnosed asthma and allergic rhinitis in Manitoba: 1985-1998. Ann Allergy Asthma Immunol. 2006;96(1):69-75.
7. Hwang CY, Chen YJ, Lin M W, et al. Prevalence of atopic dermatitis, allergic rhinitis and asthma in Taiwan: a national study 2000 to 2007. Acta Derm Venereol. 2010;90(6):589-594.
8. Gillman A, Douglass JA. Asthma in the elderly. Asia Pac Allergy. 2012;2(2):101-108.
9. Chanez P, Vignola AM, O'Shaugnessy T, et al. Corticosteroid reversibility in COPD is related to features of asthma. Am J Respir Crit Care Med. 1997;155(5):1529-1534.
10. Al-Kassimi FA, Abba AA, Al-Hajjaj MS, et al. Asthma masquerading as chronic obstructive pulmonary disease: A study of smokers fulflling the GOLD definition of chronic obstructive pulmonary disease. Respiration. 2011;82(1):19-27.
11. Bourdin A, Serre I, Flamme A, et al. Can endobronchial biopsy analysis be recommended to discriminate between asthma and COPD in routine practice? Thorax. 2004;59(6):488-493.
12. Liesker JJ, Ten Hacken NH, Zeinstra-Smith M, Rutgers SR, Postma DS, Timens W. Reticular basement membrane in asthma and COPD: similar thickness, yet different composition. Int J Chron Obstruct Pulmon Dis. 2009;4:127-135.
13. Fabbri LM, Romagnoli M, Corbetta L, et al. Differences in airway inflammation in patients with fxed airflow obstruction due to asthma or chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2003;167(3):418-424.
14. Tagaya E, Tamaoki J. Mechanisms of airway remodeling in asthma. Allergol Int. 2007;56(4):331-340.
15. Boulet L P, Turcotte H, Hudon C, et al. Clinical, physiological and radiological features of asthma with incomplete reversibility compared with those of COPD. Can Respir J. 1998;5(4):270-277.
16. Mitsunobu F, Mifune T, Ashida K, et al. Influence of age and disease severity on high resolution CT lung densitometry in asthma. Thorax. 2001;56(11):851-856.
17. Simpson JL, Milne DG, Gibson PG. Neutrophilic asthma has different radiographic features to COPD and smokers. Respir Med. 2009;103(6):881-887.
18. Frans A, Nemery B, Veriter C, Lacquet L, Francis C. Effect of alveolar volume on the interpretation of single breath DLCO. Respir Med. 1997;91(5):263-273.
19. D'Anna SE, Asnaghi R, Caramori G, et al. High-resolution computed tomography quantitation of emphysema is correlated with selected lung function values in stable COPD. Respiration. 2012;83(5):383-390.
20. Magnussen H, Richter K, Taube C. Are chronic obstructive pulmonary disease (COPD) and asthma different diseases? Clin Exp Allergy. 1998;28S(5):187-194.
21. Goedhart DM, Zanen P, Lammers J W. Relevant and redundant lung function parameters in discriminating asthma from COPD. COPD. 2006;3(1):33-39.
22. Holme J. Stockley RA. Radiology and clinical features of COPD patients with discordant pulmonary physiology. Lessons from α1-antitrypsin deficiency. Chest. 2007;132(3):909-915.
23. Mitchell RS, Stanford RE, Johnson JM, Silvers G W, Dart G, George MS. The morphologic features of the bronchi, bronchioles, and alveoli in chronic airway obstruction: a clinicopathologic study. Am Rev Respir Dis. 1976;114(1):137-145.
24. Fujimoto K, Kitaguchi Y, Kubo K, Honda T. Clinical analysis of chronic obstructive pulmonary disease phenotypes classified using highresolution computed tomography. Respirology. 2006;11(6):731-740.
25. Openbrier DR, Irwin MM, Rogers RM, et al. Nutritional status and lung function in patients with emphysema and chronic bronchitis. Chest. 1983;83(1):17-22.
26. Palmer KNV, Diament ML. A comparison of pulmonary function in bronchial asthma and chronic obstructive bronchitis. Thorax. 1970;25(1):101-104.
27. Meisner P, Hugh-Jones P. Pulmonary function in bronchial asthma. BMJ. 1968;1(5590):470-475.
28. Makita H, Nasuhara Y, Nagai K, et al. Characterisation of phenotypes based on severity of emphysema in chronic obstructive pulmonary disease. Thorax. 2007;62(11):932-937.
29. Chhabra SK. Acute bronchodilator response has limited value in differentiating bronchial asthma from COPD. J Asthma. 2005;42(5):367-372.
30. Patel IS, Vlahos I, Wilkinson TM, et al. Bronchiectasis, exacerbation indices, and inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004;170(4):400-407.
31. Martinez-Garcia MA, Soler-Cataluña JJ, Donat-Sanz Y, et al. Factors associated with bronchiectasis in patients with chronic obstructive pulmonary disease. Chest. 2011;140(5):1130-1137.
32. Garcia MA, Catalv̈na JJ. Chronic Obstructive Pulmonary disease and bronchiectasis. Arch Bronconeumol. 2010;46S(3):11-17.
33. Maestrelli P, Saetta M, Di Stefano A, et al. Comparison of leukocyte counts in sputum, bronchial biopsies, and bronchoalveolar lavage. Am J Respir Crit Care Med. 1995;152(6 Pt 1):1926-1931.
34. Stǎnescu D, Sanna A, Veriter C, et al. Airways obstruction, chronic expectoration, and rapid decline of FEV1 in smokers are associated with increased levels of sputum neutrophils. Thorax. 1996;51(3):267-271.
35. Leigh R, Pizzichini MMM, Morris MM, et al. Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment. Eur Respir J. 2006;27(5):964-971.
36. Saetta M, Di Stefano A, Maestrelli P, et al. Airway eosinophilia in chronic bronchitis during exacerbations. Am J Respir Crit Care Med. 1994;150(6 Pt 1):1646-1652.
37. Brightling CE, Monteiro W, Ward R, et al. Sputum eosinophila and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomized controlled trial. Lancet. 2000;356(9240): 1480-1485.
38. Fujimoto K, Yasuo M, Urushibata K, Hanaoka M, Koizumi T, Kubo K. Airway inflammation during stable and acutely exacerbated chronic obstructive pulmonary disease. Eur Respir J. 2005;25(4):640-646.
39. Bathoorn E, Liesker JJW, Postma DS, et al. Change in inflammation in out-patient COPD patients from stable phase to a subsequent exacerbation. Int J Chron Obstruc Pulmon Dis. 2009;4:101-109.
40. Barnes NC. Inhaled steroids in COPD. Lancet. 1998;351(9105): 766-767.
41. Barnes PJ, Shapiro SD, Pauwels RA. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J. 2003;22(4):672-688.
42. Saha S, Brightling CE. Eosinophilic airway inflammation in COPD. Int J Chron Obstruc Pulmon Dis. 2006;(1):39-47.
43. Fujimoto K, Kubo K, Yamamoto H, Yamaguchi S, Matsuzawa Y. Eosinophilic inflammation in the airway is related to glucocorticoid reversibility in patients with pulmonary emphysema. Chest. 1999;115(3):697-702.
44. Bafadhel M, Saha S, Siva R, et al. Sputum IL-5 concentration is associated with a sputum eosinophilia and attenuated by corticosteroid therapy in COPD. Respiration. 2009;78(3):256-262.
45. Brightling CE, McKenna S, Hargadon B, et al. Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease. Thorax. 2005;60(3):193-198.
46. Keatings VM, Jatakanon A, Worsdell YM, Barnes PJ. Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. Am J Respir Crit Care Med. 1997;155(2):542-548.
47. Culpitt S V, Maziak W, Loukidis S, Nightingale JA, Matthews JL, Barnes PJ. Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;160(5 Pt 1):1635-1639.
48. Loppow D, Schleiss MB, Kanniess F, Taube C, Jörres RA, Magnussen H. In patients with chronic bronchitis a four week trial with inhaled steroids does not attenuate airway inflammation. Respir Med. 2001;95(2): 115-121.
49. Gizycki MJ, Hattotuwa KL, Barnes N, Jeffery PK. Effects of futicasone propionate on inflammatory cells in COPD: an ultrastructural examination of endobronchial biopsy tissue. Thorax. 2002;57(9):799-803.
50. Hattotuwa KL, Gizycki MJ, Ansari T W, Jeffery PK, Barnes NC. The effects of inhaled futicasone on airway inflammation in chronic obstructive pulmonary disease: a double-blind, placebo-controlled biopsy study. Am J Respir Crit Care Med. 2002;165(12):1592-1596.
51. Bathoorn E, Liesker JJ, Postma DS, et al. Anti-inflammatory effects of combined budesonide/formoterol in COPD exacerbations. COPD. 2008;5(5):282-290.
52. Confalonieri M, Mainardi E, Della Porto R, et al. Inhaled corticosteroids reduce neutrophilic bronchial inflammation in patients with chronic obstructive pulmonary disease. Thorax. 1998;53(7):583-585.
53. Biernacki W, Redpath AT, Best JJ, MacNee W. Measurement of CT lung density in patients with chronic asthma. Eur Respir J. 1997; 10(11):2455-2459.
54. Nakano Y, Muro S, Sakai H, et al. Computed tomographic measurements of airway dimensions and emphysema in smokers. Correlation with lung function. Am J Respir Crit Care Med. 2000;162(3 Pt 1):1102-1108.
55. Orlandi I, Moroni C, Camiciottoli G, et al. Chronic obstructive pulmonary disease: thin-section CT measurement of airway wall thickness and lung attenuation. Radiology. 2005;234(2):604-610.
56. Nakano Y, Wong JC, de Jong PA, et al. The prediction of small airway dimensions using computed tomography. Am J Respir Crit Care Med. 2005;171(2):142-146.
57. Kosciuch J, Krenke R, Gorska K, Zukowska M, Maskey-Warzechowska M, Chazan R. Relationship between airway wall thickness assessed by high-resolution computed tomography and lung function in patients with asthma and chronic obstructive pulmonary disease. J Physiol Pharmacol. 2009;60 Suppl 5:71-76.
58. Nakano Y, Van Tho N, Yamada H, Osawa M, Nagao T. Radiological approach to asthma and COPD - the role of computed tomography. Allergol Int. 2009;58(3):323-331.
59. Harmanci E, Kebapci M, Metintas M, et al. High-resolution computed tomography fndings are correlated with disease severity in asthma. Respiration. 2002;69(5):420-426.
60. Gupta S, Siddiqui S, Haldar P, et al. Qualitative analysis of highresolution CT scans in severe asthma. Chest. 2009;136(6):1521-1528.
61. Kusaka T, Go M, Ohkubo T, et al. A case of middle lobar bulla associated with severe bronchial asthma. Kyobu Geka. 1992;45(3):279-282.
62. Ishikawa S, Yoshida I, Otaki A, et al. Surgical treatments of emphysematous giant bullae accompanied with severe bronchial asthma. Kyobu Geka. 1992;45(10):895-899.
63. Nakamura S, Matsumura A, Hashimoto Y, Kawakami M. Intrabullar suction-adhesion in a case of giant bulla of the lung with steroiddependent intractable bronchial asthma. Nihon Kyobu Shikkan Gakkai Zasshi. 1994;32(11):1115-1119.
64. Gupta P P, Yadav R, Verma M, et al. High-resolution computed tomography features in patients with chronic obstructive pulmonary disease. Singapore Med J. 2009;50(2):193-200.
65. Hersh C P, Jacobson FL, Gill R, Silverman EK. Computed tomography phenotypes in severe, early-onset chronic obstructive pulmonary disease. COPD. 2007;4(4):331-337.
66. Lee JH, Lee YK, Kim EK, et al. Responses to inhaled long-acting betaagonist and corticosteroid according to COPD subtype. Respiratory Medicine. 2010;104(4):542-549.
67. Al-Kassimi FA, Al-Hajjaj MS, Alhamad ES, et al. Abrupt withdrawal of inhaled corticosteroids in COPD does not produce spirometric deterioration: role of phenotyping. Ann Thoracic Med. 2012;7(4):238-242.
68. Al-Kassimi FA, Alhamad EH. Chronic obstructive pulmonary disease lost in translation: why are the inhaled corticosteroids skeptics refusing to go. Ann Thoracic Med. 2013. In press.
69. Zeki AA, Schivo M, Chan A, Albertson TE, Louie S. The asthma COPD overlap syndrome: A common clinical problem in the elderly. J Allergy (Cairo). 2011;2011:Article ID 861926.
70. Hardin M, Silverman EK, Barr RG, et al. The clinical features of the overlap between COPD and asthma. Respir Res. 2011;12:127.
71. Kim SR, Rhee YK. Overlap between asthma and COPD: where the two diseases converge. Allergy Asthma Immunol Res. 2010;2(4):209-214.
72. Plusa T. Overlap syndrome - asthma and chronic obstructive pulmonary disease. Pneumonol Alergol Pol. 2011;79(5):351-356.
73. Gibson PG, Simpson JL. The overlap syndrome of asthma and COPD: what are its features and how important is it? Thorax. 2009;64(8): 728-735.
74. Soler-Cataluña JJ, Cosio B, Izquierdo JL, et al. Consensus document on the overlap phenotype COPD-asthma in COPD. Arch Bronconeumol. 2012;48(9):331-337.
75. Kitaguchi Y, Komatsu Y, Fujimoto K, Hanaoka M, Kubo K. Sputum eosinophilia can predict responsiveness to inhaled corticosteroid treatment in patients with overlap syndrome of COPD and asthma. Int J Chron Obstruct Pulmon Dis. 2012;7:283-289.
76. Miravitlles M, Calle M, Soler-Cataluña JJ. Clinical phenotypes of COPD: identifcation, definition and implications for guidelines. Arch Bronchoneumol. 2012;48(3):86-98.
77. Marsh SE, Travers J, Weatherall M, et al. Proportional classifications of COPD phenotypes. Thorax. 2008;63(9):761-767.
78. Lu GL, Lin JT. The spectrum and clinical features of causes for chronic cough. Zhonghua Jie He He Hu Xi Za Zhi. 2009;32(6):422-425.
79. Smyrnios NA, Irwin RS, Curley FJ. Chronic cough with history of excessive sputum production. The spectrum and frequency of causes, key components of the diagnostic evaluation, and outcome of specifc therapy. Chest. 1995;108(4):991-997.
80. Tashkin D P, Celli B, Decramer M. et al. Bronchodilator responsiveness in patients with COPD. Eur Respir J. 2008;31(4):742-750.
81. Kauppi P, Kupiainen H, Lindqvist A, et al. Overlap syndrome of asthma and COPD predicts low quality of life. J Asthma. 2011;48(3): 279-285.